Gts Securities LLC Pfizer Inc Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$27.7 - $31.39 $587,240 - $665,468	21,200 Added 7.42%	306,800 $8.88 Million
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $2.86 Million - $3.36 Million	-113,400 Reduced 28.42%	285,600 $7.99 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $240,777 - $276,489	9,300 Added 2.39%	399,000 $11.1 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $7.73 Million - $10 Million	296,000 Added 315.9%	389,700 $11.2 Million
Q3 2023 Nov 15, 2023	BUY	$32.09 - $37.51 $3.01 Million - $3.51 Million	93,700 New	93,700 $3.11 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.